BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 1, 2015
View Archived Issues
Yakult Honsha begins Japanese phase I study of resminostat for pancreatic or biliary tract cancer
Read More
BARDA exercises additional contract funding for AEOL-10150
Read More
[18F]PTV-F1 PET: imaging liver OATP transporter
Read More
New gene therapy shows safety and efficacy for the treatment of ADA deficiency
Read More
Invion completes dosing in phase II trial of oral INV-102 in smoking cessation
Read More
Cynapsus initiates phase III trial of AP-130277 for Parkinson's disease
Read More
Phase II trial of SYN-010 begins in irritable bowel syndrome with constipation
Read More
Phase III study of Emend meets endpoint in chemotherapy-induced nausea and vomiting
Read More
FibroGen receives license payment from AstraZeneca for roxadustat
Read More
Celgene and Juno establish 10-year global immunotherapy collaboration
Read More
Clinical activity seen with AM-0010 in first-in-human trial
Read More
McMaster University develops a novel model of cancer-induced depression
Read More
Stelara receives European approval for adolescents with moderate to severe psoriasis
Read More
Vitae initiates phase I study of VTP-43742 for autoimmune disorders
Read More
New biomarker identified for anti-EGFR therapy prognosis
Read More
Combination of durvalumab with dabrafenib and/or trametinib
Read More
Merck & Co. discloses orexin OX2 receptor antagonists
Read More
Daiichi Sankyo patents LCAT activators
Read More
Bayer Schering Pharma introduces sGC activators
Read More
JST patents Abeta aggregation inhibitors
Read More
Medshine Discovery presents anti-RSV agents
Read More
Telesta Therapeutics submits BLA to the FDA for MCNA
Read More
Bayer Yakuhin launches Gadovist intravenous injection 1.0 mol/L in Japan
Read More
MJFF and MSPRF Parkinson's research foundations to merge
Read More
FDA awards QIDP designation to Innocoll's gentamicin collagen matrix for diabetic foot infections
Read More
Expanded indication for Adenuric in Europe
Read More
FDA grants fast track status to Aerucin for hospital-acquired and ventilator-associated pneumonia
Read More